An objective response rate of 29.8% was observed with patritumab deruxtecan in heavily pretreated patients…
Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan plus durvalumab with or without chemotherapy demonstrated objective response…
Medical professionals and social organizations call for increased awareness of pneumococcal threat and strengthened preventative…
HANOI, VIETNAM - Media OutReach - 9 September 2023 - President of the United States…
SINGAPORE - Media OutReach - 9 September 2023 - BingX, a top copy trading crypto…
 TAIPEI,Taiwan--(BUSINESS WIRE)--TVBS, the Taiwanese broadcasting network that kicked off operations in 1993, marks its…
HOBART, AUSTRALIA - Media OutReach - 8 September 2023 - Procreate announces the launch of…
SINGAPORE--(BUSINESS WIRE)--#insurance--AM Best has downgraded the Financial Strength Rating to B++ (Good) from A- (Excellent)…
The Australian-born brand beloved by Gen Z makes its U.S. debut SAN FRANCISCO--(BUSINESS WIRE)--a.k.a. Brands…
HONG KONG SAR - Media OutReach - 8 September 2023 - To help companies strengthen…